The next morning, the sky over Shanghai was washed silver and pale. I woke early, slipped into a simple black suit, and told my companions I'd be at the company all day. Lyra was already awake, surrounded by floating charts.
"You're sure about this, baby?" she asked, half curious, half worried. "You stayed up all night adjusting that chemical formula."
"It's not adjustment," I said, fastening my tie. "It's something new — two compounds merged from old research that doctors abandoned because they didn't have the tools to finish it."
Helion's golden projection flickered by the window. "Human labs could never stabilise both properties together. It should have been impossible."
I smiled faintly. "Then let's show them what impossible looks like when guided by balance."
Elyra's soft voice followed from the door. "Be careful, Mukul. Even miracles cause noise."
"I know," I said. "That's why I'll make sure the noise belongs to us first."
The headquarters of Eden Pharma buzzed when I arrived. The building already felt alive again — employees walking with purpose instead of fear. I passed through security silently until I reached the elevator that led to the private R&D floors.
The Head of the Department, Director Li Cheng, waited at the lab door—a middle‑aged man with silver streaks in his hair, trusted by scientists across China but once broken by corporate corruption.
"Mr Vale," he greeted nervously as I entered. "We've stabilised production lines, but our research team is running out of ideas. After the scandal, no one trusts new trials."
"That's why I'm here," I said and placed a small data crystal on his table. It contained the two formulas I had written overnight — a blend of nanotherapy sequence and bio‑regenerative compound coded by Elyra and perfected through divine ratio calculations.
Li Cheng blinked. "Two different medicines?"
"Two halves of one truth," I replied. "Individually, they only treat symptoms — lung decay and immune regression. Together, they might rebuild damaged organs entirely."
He hesitated. "You're saying regeneration?"
"Yes," I said simply. "Build, test, and don't announce anything until I say so. I want results privately — no board, no investors, no press."
He nodded, still unsure. "How soon?"
"As soon as science allows," I said, turning away with a faint smile. "And remember, Director — nothing leaves this lab until I return."
The next forty‑eight hours crawled by. I spent half of it at the villa, monitoring market graphs, and half walking through city streets disguised like an ordinary investor. Lyra handled numbers, Helion tracked shareholder behaviours, and Elyra reminded me gently to eat.
By the third evening, the message came in. "Result complete. Please return immediately."
When I entered the lab, Li Cheng and his entire team were waiting. His face glowed pale — not from exhaustion, but disbelief. When I asked, he stepped forward wordlessly, holding two vials — one faint blue, one gold.
"Mr Vale…" he breathed. Then, with a tremor of awe, he fell to one knee. "This medicine will shock the medical world."
Even his voice shook. "We tested it on damaged tissue samples. The cells revived fully — no mutation, no rejection, no loss of identity. Nothing like this exists on Earth."
I stood still, understanding the depth of what he had said. A cure — not treatment, not delay, but restoration.
Behind me, Elyra's voice whispered from the communicator, "You've given life a second rhythm."
I placed my hand gently on Li Cheng's shoulder. "Get up, Director. And remember my words — tell no one until tomorrow."
He blinked. "Tomorrow?"
"Yes," I said, already turning toward the window, city lights glimmering far below like constellations. "Because by tomorrow, this company will belong fully to us."
That night I barely slept.
Lyra projected the company's shareholder map over the villa's living room — red portions representing outside owners, blue for my shares.
"Currently, you hold seventy‑one per cent, enough for control," she said. "But as soon as the results leak, the stock value will surge. Big investors will return. You'll lose exclusivity."
"Exactly," I said. "So before dawn, we buy everything left."
Helion blinked. "All shares? That's over one hundred billion yuan in market value."
I smiled faintly. "Value changes every breath. Tonight, we own the breath."
Elyra looked at me, half-worried, half-proud. "You never think small."
"I don't need small anymore," I said quietly. "I need freedom to help without permission."
When morning came, the shareholder meeting convened in the same hall that once smelt of defeat. The largest investors gathered through holographic links, each expecting to negotiate control or reallocation.
No one expected what happened next.
Lyra, appearing on a corporate screen under the name Ms L. Vale, initiated silent transactions in the background. Helion managed algorithmic trades through offshore branches. Elyra supervised the digital encryption, ensuring no leaks.
By the time I entered the hall, half the participants had already unknowingly sold their shares back to my holding company — small offers they thought came from minor investors. It took only one hour.
A projection flickered at the centre of the table, showing 100% ownership transferred to the Vale Foundation.
Li Cheng almost dropped his pen in disbelief. "You… you bought the company overnight."
"Yes," I said simply, taking my seat at the head of the table. "Now no outside hands can twist science for greed again."
The room went silent. Even the most prideful executives had nothing left to say.
Later that evening, back at the villa, the three of them surrounded me, the glow of screens still reflecting in their eyes.
Helion exhaled slowly. "You now own one of the world's most powerful pharmaceutical networks."
Lyra smirked. "And, baby, you did it with zero meetings, one miracle formula, and two sleepless nights."
Elyra stepped close, her soft smile stealing the silence. "You changed more than a company today — you restored faith."
I looked out over the lake where the fading sunset met the city's reflection. "No," I said quietly. "I only reminded the world what healing is supposed to mean."
Behind me, they stayed silent — not out of doubt, but pride. And somewhere deep in the city, the first whispers began to spread about the impossible cure born from a company once doomed.
By dawn, humanity would call it the Miracle of Eden Pharma—a name I neither sought nor denied.
All I did was smile and whisper to myself,
"Balance restored, once more."